一类抗AIDS新药有望替代现有的“蛋白酶抑制剂”类药物
在该项试验中，科学家们联合运用Sustiva(TM)及其他三种“核苷逆转录酶抑制剂(NRTI)”类抗AIDS药物来逐步取代患者原先使用的“蛋白酶抑制剂”类药物，结果发现，16位参加试验的患者在改用了Sustiva及其他三种NRTI的联合疗法后，其体内的病毒载量被良好地控制在50拷贝/mL以下，而且原先使用\蛋白酶抑制剂\类药物治疗时所出现的副作用也消失了。
16位试验者均有不同程度的体重减轻，一般为4 kg左右，其原因是由于脂肪消耗所致。除此之外，在试验中未发现其他毒副作用。
热点推荐：
WHO concerned about growth of AIDS in Asia
AIDS battle needs greater political help
India seeks civil society inputs for AIDS Control Plan
Former US president Clinton opens AIDS clinic in Lesotho
Yao Ming wishes to invite Chinese AIDS orphans to 2008 Beijing Olympics
Cartoon deals with AIDS
NW province to offer free herbal therapy to AIDS sufferers
Traditional Chinese medicine treatment of AIDS starts in Guangxi
Angola registers 17,000 AIDS cases since 1985
HIV & AIDS Overview
WHO concerned about growth of AIDS in Asia
AIDS battle needs greater political help
India seeks civil society inputs for AIDS Control Plan
Former US president Clinton opens AIDS clinic in Lesotho
Yao Ming wishes to invite Chinese AIDS orphans to 2008 Beijing Olympics
Cartoon deals with AIDS
NW province to offer free herbal therapy to AIDS sufferers
Traditional Chinese medicine treatment of AIDS starts in Guangxi
Angola registers 17,000 AIDS cases since 1985
HIV & AIDS Overview
网上收集